GALT
GALECTIN THERAPEUTICS INC
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
86
Buys
32
Sells
31
Largest Trade
N/A
Insiders
10
Institutional Funds
72
Inst. Value
$1M+
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| ELDRED KARY | Director | BUY | <$1K | 300 | $2.70 | Feb 9, 2026 |
| LEWIS JOEL | President and CEO | EXERCISE | N/A | 84K | — | Jan 6, 2026 |
| LEWIS JOEL | President and CEO | SELL | $100K–$500K | 84K | $3.82 | Jan 6, 2026 |
| CALLICUTT JACK W | CFO | EXERCISE | N/A | 60K | — | Jan 6, 2026 |
| CALLICUTT JACK W | CFO | SELL | $100K–$500K | 60K | $3.89 | Jan 6, 2026 |
| Jamil Khurram | Chief Medical Offi… | EXERCISE | N/A | 60K | — | Jan 6, 2026 |
| Jamil Khurram | Chief Medical Offi… | SELL | $100K–$500K | 60K | $3.87 | Jan 6, 2026 |
| Jamil Khurram | Chief Medical Offi… | EXERCISE | $1K–$15K | 8K | $1.23 | Jan 5, 2026 |
| Jamil Khurram | Chief Medical Offi… | SELL | $15K–$50K | 8K | $4.07 | Jan 5, 2026 |
| ELDRED KARY | Director | BUY | $1K–$15K | 700 | $3.73 | Dec 23, 2025 |
| FREEMAN KEVIN D | Director | BUY | $15K–$50K | 6K | $3.55 | Dec 23, 2025 |
| ELDRED KARY | Director | BUY | $1K–$15K | 700 | $3.73 | Dec 23, 2025 |
| LEWIS JOEL | President and CEO | EXERCISE | $15K–$50K | 8K | $2.86 | Dec 19, 2025 |
| LEWIS JOEL | President and CEO | SELL | $50K–$100K | 8K | $7.06 | Dec 19, 2025 |
| Jamil Khurram | Chief Medical Offi… | SELL | $100K–$500K | 19K | $7.04 | Dec 19, 2025 |
| Jamil Khurram | Chief Medical Offi… | EXERCISE | $15K–$50K | 15K | $2.37 | Dec 19, 2025 |
| Shlevin Harold H. | Director | EXERCISE | $15K–$50K | 20K | $1.98 | Dec 19, 2025 |
| Shlevin Harold H. | Director | SELL | $100K–$500K | 24K | $7.04 | Dec 19, 2025 |
| 10X Fund, L.P. | 10% Owner | SELL | $100K–$500K | 31K | $6.66 | Dec 18, 2025 |
| Shlevin Harold H. | Director | EXERCISE | $100K–$500K | 28K | $4.16 | Dec 16, 2025 |
| Shlevin Harold H. | Director | SELL | $100K–$500K | 28K | $6.28 | Dec 16, 2025 |
| Shlevin Harold H. | Director | EXERCISE | $100K–$500K | 172K | $2.27 | Dec 10, 2025 |
| Shlevin Harold H. | Director | SELL | $1M+ | 176K | $6.00 | Dec 10, 2025 |
| 10X Fund, L.P. | 10% Owner | SELL | $500K+ | 150K | $5.68 | Dec 4, 2025 |
| LEWIS JOEL | President and CEO | SELL | $100K–$500K | 22K | $6.07 | Nov 19, 2025 |
| LEWIS JOEL | President and CEO | EXERCISE | $50K–$100K | 22K | $2.39 | Nov 19, 2025 |
| CALLICUTT JACK W | CFO | EXERCISE | $100K–$500K | 78K | $1.53 | Nov 19, 2025 |
| CALLICUTT JACK W | CFO | SELL | $100K–$500K | 78K | $6.15 | Nov 19, 2025 |
| Jamil Khurram | Chief Medical Offi… | SELL | $500K+ | 121K | $5.47 | Nov 14, 2025 |
| Jamil Khurram | Chief Medical Offi… | EXERCISE | $100K–$500K | 99K | $2.17 | Nov 14, 2025 |
| 10X Fund, L.P. | 10% Owner | SELL | $100K–$500K | 40K | $5.25 | Nov 12, 2025 |
| LEWIS JOEL | President and CEO | EXERCISE | $1K–$15K | 2K | $2.39 | Nov 12, 2025 |
| LEWIS JOEL | President and CEO | SELL | $1K–$15K | 2K | $6.03 | Nov 12, 2025 |
| CALLICUTT JACK W | CFO | SELL | $15K–$50K | 5K | $6.03 | Nov 12, 2025 |
| CALLICUTT JACK W | CFO | EXERCISE | $1K–$15K | 5K | $1.46 | Nov 12, 2025 |
| LEWIS JOEL | President and CEO | SELL | $1K–$15K | 200 | $6.00 | Nov 7, 2025 |
| LEWIS JOEL | President and CEO | EXERCISE | <$1K | 200 | $2.39 | Nov 7, 2025 |
| CALLICUTT JACK W | CFO | EXERCISE | <$1K | 600 | $1.60 | Nov 7, 2025 |
| CALLICUTT JACK W | CFO | SELL | $1K–$15K | 600 | $6.00 | Nov 7, 2025 |
| LEWIS JOEL | President and CEO | EXERCISE | $15K–$50K | 16K | $2.39 | Nov 5, 2025 |
| LEWIS JOEL | President and CEO | SELL | $50K–$100K | 16K | $6.07 | Nov 5, 2025 |
| CALLICUTT JACK W | CFO | EXERCISE | $50K–$100K | 32K | $1.61 | Nov 5, 2025 |
| CALLICUTT JACK W | CFO | SELL | $100K–$500K | 32K | $6.06 | Nov 5, 2025 |
| 10X Fund, L.P. | 10% Owner | SELL | $100K–$500K | 50K | $4.94 | Oct 25, 2025 |
| CALLICUTT JACK W | CFO | SELL | $50K–$100K | 9K | $6.44 | Sep 15, 2025 |
| CALLICUTT JACK W | CFO | EXERCISE | $1K–$15K | 9K | $1.37 | Sep 15, 2025 |
| LEWIS JOEL | President and CEO | SELL | $50K–$100K | 14K | $6.36 | Sep 15, 2025 |
| LEWIS JOEL | President and CEO | EXERCISE | $15K–$50K | 14K | $2.39 | Sep 15, 2025 |
| ELDRED KARY | Director | BUY | $1K–$15K | 1K | $2.92 | Jul 22, 2025 |
| FREEMAN KEVIN D | Director | BUY | $1K–$15K | 5K | $2.90 | Jul 18, 2025 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 72 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Wealthspire Advisors, LLC | 602K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 492K | $1M+ | SH |
| COMMONWEALTH EQUITY SERVICES, LLC | 334K | $1M+ | SH |
| LPL Financial LLC | 325K | $1M+ | SH |
| Geneos Wealth Management Inc. | 243K | $1M+ | SH |
| STATE STREET CORP | 242K | $1M+ | SH |
| Vivaldi Capital Management LP | 204K | $500K+ | SH |
| RETIREMENT GUYS FORMULA LLC | 185K | $500K+ | SH |
| Sovran Advisors, LLC | 226K | $500K+ | SH |
| MARSHALL WACE, LLP | 129K | $500K+ | SH |
| Cambridge Investment Research Advisors, Inc. | 126K | $500K+ | SH |
| Fortis Capital Advisors, LLC | 106K | $100K–$500K | SH |
| Belpointe Asset Management LLC | 106K | $100K–$500K | SH |
| GSA CAPITAL PARTNERS LLP | 102K | $100K–$500K | SH |
| Traynor Capital Management, Inc. | 102K | $100K–$500K | SH |
| HighTower Advisors, LLC | 88K | $100K–$500K | SH |
| Hudson Bay Capital Management LP | 78K | $100K–$500K | SH |
| TRUIST FINANCIAL CORP | 68K | $100K–$500K | SH |
| OMERS ADMINISTRATION Corp | 63K | $100K–$500K | SH |
| Virtu Financial LLC | 54K | $100K–$500K | SH |